we're not just a stock market game
Sign up free
Alexion Pharmaceuticals Inc (ALXN)
This biotech firm goes after the heavy hitters of the disease world: leukemia, cancer, and asthma in its drug development department.
There are no posts at this time.
Events
-
June 42012Alexion Pharmaceuticals, Inc. Presents at Jefferies 2012 Global Healthcare Conference, Jun-04-2012 10:30 AM
-
July212012Alexion Pharmaceuticals, Inc. expected to report Q2 2012 results on July 21, 2012. This event was calculated by Capital IQ (Created on April 25, 2012).
-
February 92013Alexion Pharmaceuticals, Inc. expected to report Fiscal Year 2012 results on February 9, 2013. This event was calculated by Capital IQ (Created on April 26, 2012).
Members who own this company also own
$93.66
Current price per share
Today's gain: $4.90 (5.50%)
Is this a fair price given publicly available information?
(Not an indicator of whether the price will go up or down.)
